# Continuous Glucose Monitoring as Adjunct to Lifestyle Modification in Prediabetes

Study · id `cardio:ct-nct04588896` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04588896](<https://clinicaltrials.gov/study/NCT04588896>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT04588896

Browse, organ or system: Metabolism  
Browse, condition area: Risk and prevention; Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 177 participants.

## Technical summary

Registry record NCT04588896. Randomized; no masking; primary purpose prevention. Start 2020-12-01 (actual); primary completion 2024-01-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 177 participants (enrolled count; ClinicalTrials.gov record NCT04588896, source copy `cardio:ctgov-nct04588896-2025-03-05`, retrieved 2026-11-18)
- Started: 2020-12-01 (actual) (ClinicalTrials.gov record NCT04588896, source copy `cardio:ctgov-nct04588896-2025-03-05`, retrieved 2026-11-18)
- Primary completion: 2024-01-31 (actual) (ClinicalTrials.gov record NCT04588896, source copy `cardio:ctgov-nct04588896-2025-03-05`, retrieved 2026-11-18)
- Completion: 2024-01-31 (actual) (ClinicalTrials.gov record NCT04588896, source copy `cardio:ctgov-nct04588896-2025-03-05`, retrieved 2026-11-18)
- Countries: Hong Kong SAR China (ClinicalTrials.gov record NCT04588896, source copy `cardio:ctgov-nct04588896-2025-03-05`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04588896-2025-03-05`, retrieved 2026-11-18)

## The registry's words

- Brief title: Continuous Glucose Monitoring as Adjunct to Lifestyle Modification in Prediabetes
- Acronym: FlashLMP
- Condition: PreDiabetes
- Intervention (Device): Continuous glucose monitoring
- Intervention (Behavioral): Lifestyle modification programme
- Lead sponsor: Chinese University of Hong Kong
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Prediabetes (`cardio:prediabetes`)
- Registry lists this organization as the lead sponsor: Chinese University of Hong Kong (`cardio:org-chinese-university-of-hong-kong`)

## Provenance

Content hash: da0db11151ab97fc9af68c0eff21f14b2412f92d5693adb52fd5373993668c8a
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
